Skip to main content

Analysis

Molina to Waive COVID-19 Testing and Treatment Costs for Rest of 2020

By Jack O'Brien  
   June 08, 2020

The Long Beach, California–based insurer also covers office visits, urgent care, and ER visits related to the coronavirus outbreak.

Molina Healthcare announced Monday that it will waive out-of-pocket costs related to the testing and treatment for coronavirus disease 2019 (COVID-19) through the end of 2020.

The Long Beach, California–based insurer committed to extending its partnership with Teladoc Health, free home delivery of prescription drugs through CVS Pharmacy, and offering a 'Coronavirus Chatbot' for its members.

Molina also covers office visits, urgent care, and emergency room visits related to the coronavirus outbreak.

"We want to entirely remove the burden of any expenses associated with testing and treatment for COVID-19," Jason Dees, chief medical officer of Molina, said in a statement. "Molina will continue to waive cost-sharing for all of our members using in-network providers."

Related: Molina Healthcare Backs Away From NextLevel Purchase

Despite the uncertainties surrounding the ongoing pandemic, Molina reaffirmed its full year financial guidance as part of its latest earnings report release last month.

The company projected that its earnings per share will be in a range between $11.20 to $11.70, with a total revenue of $18.3 billion.

Related: Molina Reaffirms 2020 Guidance, Announces $820M Deal With Magellan

Jack O'Brien is the finance editor at HealthLeaders, a Simplify Compliance brand.

Photo credit: Photo credit: KIEV, UKRAINE - Dec 18, 2018: Molina Healthcare company logo seen displayed on smartphone - Image / Editorial credit: IgorGolovniov / Shutterstock.com


Get the latest on healthcare leadership in your inbox.